1. Home
  2. VSEC vs IBRX Comparison

VSEC vs IBRX Comparison

Compare VSEC & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEC
  • IBRX
  • Stock Information
  • Founded
  • VSEC 1959
  • IBRX 2014
  • Country
  • VSEC United States
  • IBRX United States
  • Employees
  • VSEC N/A
  • IBRX N/A
  • Industry
  • VSEC Military/Government/Technical
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSEC Consumer Discretionary
  • IBRX Health Care
  • Exchange
  • VSEC Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • VSEC 2.1B
  • IBRX 2.4B
  • IPO Year
  • VSEC N/A
  • IBRX N/A
  • Fundamental
  • Price
  • VSEC $117.33
  • IBRX $2.97
  • Analyst Decision
  • VSEC Strong Buy
  • IBRX Strong Buy
  • Analyst Count
  • VSEC 6
  • IBRX 5
  • Target Price
  • VSEC $118.67
  • IBRX $11.35
  • AVG Volume (30 Days)
  • VSEC 247.3K
  • IBRX 5.7M
  • Earning Date
  • VSEC 05-07-2025
  • IBRX 03-03-2025
  • Dividend Yield
  • VSEC 0.34%
  • IBRX N/A
  • EPS Growth
  • VSEC N/A
  • IBRX N/A
  • EPS
  • VSEC 0.85
  • IBRX N/A
  • Revenue
  • VSEC $1,080,132,000.00
  • IBRX $14,745,000.00
  • Revenue This Year
  • VSEC N/A
  • IBRX $621.53
  • Revenue Next Year
  • VSEC $12.06
  • IBRX $163.57
  • P/E Ratio
  • VSEC $137.64
  • IBRX N/A
  • Revenue Growth
  • VSEC 25.53
  • IBRX 2270.58
  • 52 Week Low
  • VSEC $73.36
  • IBRX $2.28
  • 52 Week High
  • VSEC $128.72
  • IBRX $10.53
  • Technical
  • Relative Strength Index (RSI)
  • VSEC 50.47
  • IBRX 49.44
  • Support Level
  • VSEC $110.15
  • IBRX $2.90
  • Resistance Level
  • VSEC $126.00
  • IBRX $3.26
  • Average True Range (ATR)
  • VSEC 5.43
  • IBRX 0.22
  • MACD
  • VSEC -0.61
  • IBRX 0.03
  • Stochastic Oscillator
  • VSEC 38.64
  • IBRX 36.71

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: